OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 10 filers reported holding OPIANT PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $56,825 | +255.2% | 2,802 | +93.8% | 0.00% | – |
| Q3 2022 | $16,000 | +14.3% | 1,446 | +22.5% | 0.00% | – |
| Q2 2022 | $14,000 | -36.4% | 1,180 | +15.5% | 0.00% | – |
| Q1 2022 | $22,000 | +120.0% | 1,022 | +235.1% | 0.00% | – |
| Q4 2021 | $10,000 | -9.1% | 305 | -30.4% | 0.00% | – |
| Q3 2021 | $11,000 | -31.2% | 438 | -63.3% | 0.00% | – |
| Q2 2021 | $16,000 | 0.0% | 1,195 | -38.5% | 0.00% | – |
| Q4 2020 | $16,000 | +23.1% | 1,943 | +12.8% | 0.00% | – |
| Q3 2020 | $13,000 | -7.1% | 1,722 | +78.6% | 0.00% | – |
| Q4 2019 | $14,000 | -53.3% | 964 | -56.9% | 0.00% | – |
| Q1 2019 | $30,000 | +36.4% | 2,235 | +44.6% | 0.00% | – |
| Q4 2018 | $22,000 | -66.2% | 1,546 | -57.2% | 0.00% | – |
| Q3 2018 | $65,000 | +132.1% | 3,615 | +82.2% | 0.00% | – |
| Q2 2018 | $28,000 | -62.7% | 1,984 | -49.1% | 0.00% | – |
| Q1 2018 | $75,000 | +158.6% | 3,900 | +200.9% | 0.00% | – |
| Q4 2017 | $29,000 | +262.5% | 1,296 | +494.5% | 0.00% | – |
| Q3 2017 | $8,000 | – | 218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Independence Bank of Kentucky | 100 | $1,000 | 0.00% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 4,429 | $63,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 431 | $6,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 6,418 | $92,000 | 0.00% |
| BlackRock Inc. | 6,734 | $97,000 | 0.00% |
| ROYAL BANK OF CANADA | 3,788 | $55,000 | 0.00% |
| Gradient Investments LLC | 350 | $5,000 | 0.00% |
| VANGUARD GROUP INC | 84,281 | $1,204,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 455 | $9,000 | 0.00% |
| UBS Group AG | 1,984 | $28,000 | 0.00% |